CBMG

Cellular Biomedicine Group, Inc.
CBMG

Delisted

CBMG was delisted on the 19th of February, 2021.

Back to rankings

25 hedge funds and large institutions have $12.2M invested in Cellular Biomedicine Group, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $209K

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$209K
Net Calls
Net Calls Change

Top Buyers

1
+$1.03M
2
+$927K
3
+$755K
4
TEE
Tibra Equities Europe
United Kingdom
+$487K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$303K

Top Sellers

1
-$114K
2
-$30.1K
3
-$10.5K
4
MAM
Meeder Asset Management
Ohio
-$9.36K
5
Simplex Trading
Simplex Trading
Illinois
-$7.37K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
1
2